Abstract 47 Table 1
All, n=90 (%)AS-Present, n=19 (%)AS-Absent, n=71 (%)P-value
Age, years64.2 ± 1.166.3 ± 2.263.7 ± 1.30.33
Gender (female)62 (68.9)10 (52.6)52 (73.2)0.10
BMI, kg/m2 26.6 ± 0.627.1 ± 1.226.5 ± 0.70.69
Diabetes Mellitus14 (15.6)0 (0)14 (19.7)0.04*
Hypertension50 (55.6)13 (68.4)37 (52.1)0.29
Coronary Artery Disease20 (22.2)6 (31.6)14 (19.7)0.35
Dyslipidemia41 (45.6)10 (52.6)31 (43.7)0.61
Chronic Obstructive Pulmonary Disease11 (12.2)4 (21.0)7 (9.9)0.24
Smoker (>10 pack years)41 (45.6)11 (57.9)30 (42.3)0.30
Chronic Kidney Disease18 (20.0)5 (26.3)13 (18.3)0.52
Scleroderma Type
Limited Cutaneous72 (80.0)17 (89.5)55 (77.5)0.34
Diffuse Cutaneous12 (13.3)1 (5.3)11 (15.5)0.45
Overlap Syndrome4 (4.4)0 (0.0)4 (5.6)0.58
Sine2 (2.2)1 (5.3)1 (1.4)0.38
Scleroderma Manifestations
Telangiectasias82 (91.1)18 (94.7)64 (90.1)0.99
Raynaud’s phenomenon88 (97.8)18 (94.7)70 (98.6)0.38
Sclerodactyly76 (84.4)17 (89.5)59 (83.1)0.73
Calcinosis Cutis29 (32.2)7 (36.8)22 (30.1)0.78
GERD71 (78.9)13 (68.4)58 (81.7)0.22
Antibody Profile
Anti-Centromere36 (40.0)9 (47.4)27 (30.0)0.60
SCl-7011 (12.2)1 (5.3)10 (14.1)0.45
SSB or SSA10 (11.1)1 (5.3)9 (12.7)0.68
Rheumatoid Factor9 (10.0)1 (5.3)8 (11.3)0.68
RNA Polymerase II1 (1.1)0 (0)1 (1.4)0.99
Anti-U1-RNP3 (3.3)0 (0)3 (4.2)0.99
Interstitial Lung Disease36 (40.0)7 (36.8)29 (40.8)0.80
  • *Statistically significant at p<0.05, the unpaired t-test with Welch’s correction was used for continuous variables and the Fischer-exact test was used for categorical variables. Variance= standard error